Biotech Values

[turtlepower]

Here's an interesting point:

For more than half of the 16 patients, worsening arthritis and the need for surgery occurred in a joint other than the one originally targeted in the study, the researchers said. One patient developed a problem in the shoulder, an uncommon location for damage from osteoarthritis.

http://www.bloomberg.com/news/2010-09-29/pfizer-arthritis-drug-cut-pain-too-well-leading-to-joint-damage-in-study.html

If the other joints were in a better condition than the targeted joint I think it does support the theory that tanezumab has a good pain masking ability which led to joint deterioration.